Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers

Clinical trial NCT05582031 · WITHDRAWN

Trial details

NCT number: NCT05582031
Sponsor: Translational Research in Oncology
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Anal Squamous Cell Carcinoma Colorectal Neoplasms Soft Tissue Sarcoma Malignant Pleural Mesothelioma Small Cell Lung Carcinoma Castrate Resistant Prostate Cancer Neuroendocrine Carcinoma of Prostate Gastroenteropancreatic Neuroendocrine Neoplasm

Start date: 2023-04-30
Primary completion: 2025-04-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.